Financials
Financial year 2025
Pharma Kenis from Geel, company number BE0644677737, closed financial year 2025 with a result of € 143,121 after tax. For that financial year Pharma Kenis recorded a gross margin of € 231,518 and equity of € 921,259. Compared with financial year 2024, the result moved from € 163,057 to € 143,121. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on May 26, 2026.
€ 921,259
▲ 18% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 143,121
▼ 12% vs 2024
Profit after tax over the fiscal year.
€ 169,559
▲ € 140,437 vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 908,859.
People and assets in 2025
€ 26,616
▼ 28% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 346,714
▼ 43% vs 2024
€ 89,206 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.
€ 1,571
▲ 9% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 8,212
▼ 65% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 208,711 | € 209,891 | € 255,696 | € 231,518 | ▼ 9% |
| Profit after taxes | € 152,156 | € 144,598 | € 163,057 | € 143,121 | ▼ 12% |
| Equity | € 580,983 | € 667,581 | € 778,138 | € 921,259 | ▲ 18% |
| Total debts | € 610,712 | € 738,314 | € 811,305 | € 356,641 | ▼ 56% |
| Cash | € 134,483 | € 115,562 | € 29,122 | € 169,559 | ▲ € 140,437 |
| Retained profit | € 568,583 | € 655,181 | € 765,738 | € 908,859 | ▲ 19% |
| Dividend | € 0 | € 58,000 | € 52,500 | € 0 | ▼ 100% |
| Bank debt | € 603,933 | € 673,400 | € 607,551 | € 346,714 | ▼ 43% |
| Balance sheet total | € 1,191,695 | € 1,405,895 | € 1,589,443 | € 1,277,900 | ▼ 20% |
Key figures of Pharma Kenis, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 April 2027.
What happened to Pharma Kenis?
What happened at Pharma Kenis in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 143,121 (▼ 12% vs 2024). filed late Source: NBB ↗
- New establishment in Geel. KBO
- Start of the company according to the CBE. KBO
- Kristof Kenis became a director. NBB
In short
From € 152,156 profit in 2022 to € 143,121 profit in 2025.
Paid € 248,751 in corporate taxes since 2022.
Best year ever: 2024, with € 163,057 profit.
Paid out € 110,500 in dividends to the owners in total.
A new publication or filing at Pharma Kenis? We notify you, reason included.
Follow Pharma KenisDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind Pharma Kenis is Kristof Kenis. Kristof Kenis is also behind Apotheek BAKELANTS and Apotheek Sint-Dimpna.
Directors
According to the 2025 annual accounts
since 2015
Establishments
Establishment units
Physical locations of this company
Kollegestraat 26
2440 Geel
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0644.677.737
- VAT number
- BE 0644.677.737
- Registered office
- Kollegestraat 26, 2440 Geel
- Names & denominations
- Pharma Kenis
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 19 December 2015
- Peppol
- Active · Active since 30 Jun 2025
- Activities · NACE
Detailhandel in farmaceutische producten
Activiteiten van holdings
Overige zakelijke dienstverlening, neg
Holdings